Q4 EPS Estimates for Ayr Wellness Reduced by Seaport Res Ptn

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Research analysts at Seaport Res Ptn lowered their Q4 2024 EPS estimates for Ayr Wellness in a report released on Sunday, November 24th. Seaport Res Ptn analyst S. Randhawa now expects that the company will earn ($0.26) per share for the quarter, down from their prior forecast of ($0.24). The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Seaport Res Ptn also issued estimates for Ayr Wellness’ Q1 2025 earnings at ($0.24) EPS, Q2 2025 earnings at ($0.22) EPS, Q3 2025 earnings at ($0.21) EPS, Q4 2025 earnings at ($0.20) EPS and FY2025 earnings at ($0.87) EPS.

Several other research analysts have also commented on AYRWF. Roth Capital upgraded Ayr Wellness to a “strong-buy” rating in a research report on Friday, November 8th. Roth Mkm dropped their target price on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating for the company in a report on Thursday, November 14th. Finally, Atb Cap Markets lowered Ayr Wellness from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 13th.

Ayr Wellness Stock Performance

Ayr Wellness stock opened at $0.71 on Wednesday. The company’s 50-day moving average price is $1.60 and its 200-day moving average price is $1.89. The company has a quick ratio of 0.58, a current ratio of 1.59 and a debt-to-equity ratio of 0.76. The company has a market cap of $81.05 million, a PE ratio of -0.32 and a beta of 2.00. Ayr Wellness has a twelve month low of $0.62 and a twelve month high of $4.09.

Ayr Wellness Company Profile

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.